Skip to content
Peptide research

Hexarelin

Also known as Examorelin
Category
Growth Hormone
Administration routes
Injectable
Regulatory status
Not FDA-approved

What it is

A synthetic growth hormone secretagogue, the most potent of its class, used for muscle growth, recovery, and a claimed heart-protective effect. It reliably triggers a growth hormone surge in humans, but the heart, anti-fibrotic, and lipid benefits rest mainly on animal and mechanism-only studies. A known drawback is fast tolerance, plus prolactin and cortisol effects. It is not FDA-approved and is sold mostly as unregulated research product.

Read Full record

Studied uses & evidence

Studied uses(6)

  • Potent growth hormone release

    High

    Multiple human studies confirm dose-dependent growth hormone release, exceeding GHRH in direct comparison.

  • Cardioprotection and improved cardiac function

    Medium

    Small human studies, including controlled comparisons, show acute cardiac function improvement in some but not all conditions.

  • Anti-fibrotic cardiac effects

    Low

    Reduced cardiac fibrosis in rodent and cell studies only; no human data available.

Evidence limits

Evidence Level
Phase II — Moderate

Hexarelin reached Phase II clinical trials for GH deficiency and congestive heart failure. Human studies (total ~50 subjects across multiple trials) demonstrate consistent GH release and acute cardioprotective effects. However, development was discontinued before Phase III, tolerance development limits chronic use, and the compound was never marketed. Preclinical evidence for cardioprotection is robust, but translational human data remains limited.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Active cancer

    High

    GH secretagogue — sustained GH/IGF-1 elevation promotes tumor growth.

  • Diabetic retinopathy

    High

    GH/IGF-1 elevation can worsen proliferative retinopathy.

  • Cardiovascular disease (severe)

    Moderate

    Hexarelin has direct cardiac effects via CD36 receptors. Use caution with existing heart conditions.

  • Diabetes/insulin resistance

    Moderate

    GH elevation can impair glucose tolerance and worsen insulin resistance.

Risk summary(7)

Risks = level of concern: High · Moderate · Low · Theoretical

  • Unapproved compound

    High
  • Limited long-term human safety data

    High
  • HPA axis stimulation

    Moderate
  • Prolactin elevation

    Moderate
  • Tolerance development

    Moderate
  • Potential IGF-1 elevation concerns

    Theoretical
  • Water retention and joint discomfort

    Theoretical
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.